Author： Burnier Michel
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 491-499
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. :
Access to resources
Recommend
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. :
Rofecoxib: Hepatitis: case report
Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. :
The "coadministration of rofecoxib and tizanidine is best avoided"
Reactions Weekly, Vol. 1, Iss. 1124, 2006-01 ,pp. :